DSV Group has launched a dedicated pharmaceutical air freight service connecting Luxembourg and Indianapolis, strengthening its healthcare logistics network and enhancing transatlantic transportation options for temperature-sensitive medical products.
The new route has been designed to support the growing demand for reliable and compliant pharmaceutical logistics solutions between Europe and the United States. By linking two major healthcare and life sciences hubs, DSV aims to provide faster transit times, improved supply chain visibility and enhanced cargo security for pharmaceutical manufacturers and distributors.
The service will focus on the movement of temperature-controlled products, including vaccines, biologics, clinical trial materials and other high-value healthcare shipments that require strict handling standards throughout the transportation process. Maintaining product integrity is a critical requirement for pharmaceutical supply chains, making specialized logistics infrastructure essential.
Luxembourg serves as a key European air cargo gateway with well-established pharmaceutical handling capabilities, while Indianapolis is one of the leading healthcare and life sciences logistics centers in the United States. The direct connection is expected to improve supply chain efficiency and provide greater flexibility for customers operating in both markets.
The launch reflects growing demand for dedicated healthcare logistics services as pharmaceutical companies expand global production networks and seek more resilient transportation solutions. Industry stakeholders have increasingly emphasized the importance of secure, temperature-controlled air freight services to ensure uninterrupted delivery of critical medical products.
DSV has continued to invest in its healthcare logistics portfolio through the development of specialized facilities, advanced monitoring technologies and regulatory-compliant transportation services. The new air corridor forms part of the company’s broader strategy to strengthen its position in the global life sciences and healthcare logistics sector.
Industry analysts note that pharmaceutical logistics remains one of the fastest-growing segments of the air cargo market, driven by increasing demand for biologics, personalized medicines and complex healthcare products that require rapid and carefully controlled transportation.
The Luxembourg–Indianapolis service is expected to enhance DSV’s ability to support pharmaceutical customers with end-to-end cold chain solutions while reinforcing the resilience and reliability of transatlantic healthcare supply chains.
